Moreover, further research comparing P16 and P57 expression in rsCRC, ocCRC, and normal colonic tissue from corresponding locations will add valuable insights into understanding these proteins' role and their modulation effect in personalized CRC therapy. Here, CDKN2A is linked to colorectal carcinoma.